Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Apotex First In US To Recall OTC Ranitidine Tablets Due To NDMA Impurity

Sep 26 2019

• By Malcolm Spicer

Apotex exterior

Related Content

US Zantac Sales And Distribution Continue As Sanofi Tests For NDMA

Sep 23 2019

Online Pharmacy Stirs Ranitidine Controversy With Petition To Halt Sales

Sep 15 2019

Related Companies

Apotex Inc.

Walgreen Co.

Rite Aid Corp.

Sanofi

Novartis AG

Novartis AG

Additional Topics

Europe United States OTC Drugs Drug Safety Recalls Advertising, Marketing & Sales Commercial Companies Compliance Distribution FDA Manufacturing Policy Regulation Consumer

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.